Drug against central nervous system inflammation
A central nervous system, drug technology, applied in nervous system diseases, neuromuscular system diseases, anti-inflammatory agents, etc., can solve problems such as brain damage, death, coma, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
preparation example 1
[0170] Preparation Example 1: Preparation of Fraction Containing Plasmalogen Extracted from Biological Tissue
[0171] Chicken skin, which is a poultry tissue, was collected according to a currently known method, cut into minced meat with a size of about 8 mm, and then heated and compressed using a press to remove neutral lipids, thereby preparing defatted chicken skin. The defatted chicken skin is then freeze-dried and crushed by a conventional method, thereby obtaining the defatted chicken skin dry powder. The defatted chicken skin dry powder is stored airtightly together with a deoxidizer until it is used for extraction.
[0172] Organic solvent extraction steps
[0173] step 1)
[0174] To 1 kg of the dry chicken skin powder obtained above was added 2 L of ethanol, and the resulting solution was stirred at 40° C. for 12 hours, and left to stand. Afterwards, the extraction solution is separated from the solid. 2 L of ethanol was added to the solid, and extraction was ...
Embodiment 1
[0192] Example 1: Investigation of central inflammation prevention effect of plasmalogen extracted from biological tissue
[0193] The following experiment was carried out to investigate the effect of plasmalogen extracted from poultry tissue on central nervous system inflammation.
[0194] Preparation of model mice and administration of test substances
[0195] Brain inflammation model mice were generated in the same manner as in Non-Patent Document 2 (Lee JW et al., Neuroinflammation. 2008-29; 5:37). More specifically, LPS (lipopolysaccharide), which is a stimulator of TLR4 (Toll-like receptor 4), was intraperitoneally administered to mice for several consecutive days, thereby generating chronic brain inflammation model mice.
[0196] Specifically, four male C57BL mice (Kyudo Co., Ltd.) aged 8 to 12 weeks were intraperitoneally administered LPS (250 μg / kg, Sigma Aldrich) once a day for seven consecutive days, thereby obtaining brain inflammation model mice . A control g...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com